A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss
- PMID: 20101008
- DOI: 10.1001/archinternmed.2009.492
A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss
Erratum in
-
Error in figure.JAMA Intern Med. 2015 Mar;175(3):470. doi: 10.1001/jamainternmed.2015.8. JAMA Intern Med. 2015. PMID: 25730581 No abstract available.
Abstract
Background: Two potent weight loss therapies, a low-carbohydrate, ketogenic diet (LCKD) and orlistat therapy combined with a low-fat diet (O + LFD), are available to the public but, to our knowledge, have never been compared.
Methods: Overweight or obese outpatients (n = 146) from the Department of Veterans Affairs primary care clinics in Durham, North Carolina, were randomized to either LCKD instruction (initially, <20 g of carbohydrate daily) or orlistat therapy, 120 mg orally 3 times daily, plus low-fat diet instruction (<30% energy from fat, 500-1000 kcal/d deficit) delivered at group meetings over 48 weeks. Main outcome measures were body weight, blood pressure, fasting serum lipid, and glycemic parameters.
Results: The mean age was 52 years and mean body mass index was 39.3 (calculated as weight in kilograms divided by height in meters squared); 72% were men, 55% were black, and 32% had type 2 diabetes mellitus. Of the study participants, 57 of the LCKD group (79%) and 65 of the O + LFD group (88%) completed measurements at 48 weeks. Weight loss was similar for the LCKD (expected mean change, -9.5%) and the O + LFD (-8.5%) (P = .60 for comparison) groups. The LCKD had a more beneficial impact than O + LFD on systolic (-5.9 vs 1.5 mm Hg) and diastolic (-4.5 vs 0.4 mm Hg) blood pressures (P < .001 for both comparisons). High-density lipoprotein cholesterol and triglyceride levels improved similarly within both groups. Low-density lipoprotein cholesterol levels improved within the O + LFD group only, whereas glucose, insulin, and hemoglobin A(1c) levels improved within the LCKD group only; comparisons between groups, however, were not statistically significant.
Conclusion: In a sample of medical outpatients, an LCKD led to similar improvements as O + LFD for weight, serum lipid, and glycemic parameters and was more effective for lowering blood pressure.
Trial registration: clinicaltrials.gov Identifier: NCT00108524.
Comment in
-
Tackling obesity: is primary care up to the challenge?Arch Intern Med. 2010 Jan 25;170(2):121-3. doi: 10.1001/archinternmed.2009.479. Arch Intern Med. 2010. PMID: 20101005 No abstract available.
-
Low-carbohydrate ketogenic diet and the combination of orlistat with a low-fat diet lead to comparable improvements in weight and blood lipids, but LCKD more beneficial for blood pressure.Evid Based Med. 2010 Jun;15(3):91-2. doi: 10.1136/ebm1065. Evid Based Med. 2010. PMID: 20522693 No abstract available.
Similar articles
-
Acid-base analysis of individuals following two weight loss diets.Eur J Clin Nutr. 2007 Dec;61(12):1416-22. doi: 10.1038/sj.ejcn.1602661. Epub 2007 Feb 14. Eur J Clin Nutr. 2007. PMID: 17299473 Clinical Trial.
-
X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.Diabetes Obes Metab. 2005 Nov;7(6):699-708. doi: 10.1111/j.1463-1326.2005.00483.x. Diabetes Obes Metab. 2005. PMID: 16219013 Clinical Trial.
-
The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.Int J Obes Relat Metab Disord. 2001 Nov;25(11):1713-21. doi: 10.1038/sj.ijo.0801814. Int J Obes Relat Metab Disord. 2001. PMID: 11753595 Clinical Trial.
-
Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials.Br J Nutr. 2013 Oct;110(7):1178-87. doi: 10.1017/S0007114513000548. Epub 2013 May 7. Br J Nutr. 2013. PMID: 23651522 Review.
-
The cost effectiveness of orlistat in a 1-year weight-management programme for treating overweight and obese patients in Sweden : a treatment responder approach.Pharmacoeconomics. 2005;23(10):1007-20. doi: 10.2165/00019053-200523100-00004. Pharmacoeconomics. 2005. PMID: 16235974 Review.
Cited by
-
Effect of Allowing Choice of Diet on Weight Loss: A Randomized Trial.Ann Intern Med. 2015 Jun 16;162(12):805-14. doi: 10.7326/M14-2358. Ann Intern Med. 2015. PMID: 26075751 Free PMC article. Clinical Trial.
-
Role of Nutrition and Exercise Programs in Reducing Blood Pressure: A Systematic Review.J Clin Med. 2019 Sep 5;8(9):1393. doi: 10.3390/jcm8091393. J Clin Med. 2019. PMID: 31492032 Free PMC article. Review.
-
Metformin use amid coronavirus disease 2019 pandemic.J Med Virol. 2020 Nov;92(11):2401-2402. doi: 10.1002/jmv.26090. Epub 2020 Jun 9. J Med Virol. 2020. PMID: 32470199 Free PMC article. No abstract available.
-
The impact of ketogenic diet on some metabolic and non-metabolic diseases: Evidence from human and animal model experiments.Food Sci Nutr. 2024 Jan 8;12(3):1444-1464. doi: 10.1002/fsn3.3873. eCollection 2024 Mar. Food Sci Nutr. 2024. PMID: 38455178 Free PMC article. Review.
-
Recruitment and Retention for a Weight Loss Maintenance Trial Involving Weight Loss Prior to Randomization.Obes Sci Pract. 2016 Dec;2(4):355-365. doi: 10.1002/osp4.58. Epub 2016 Aug 26. Obes Sci Pract. 2016. PMID: 28090340 Free PMC article.